glp-1 gip news Science Behind GLP 1 and Glucagon Receptor Agonists for Obesity Research | & Announcements Upcoming wave of hormone-based therapies

These medications not only promote significant weight loss, which reduces airway obstruction but may also improve neuromuscular control of breathing

The global GLP-1 market is on a significant growth trajectory, anticipated to rise from an estimated $44.5 million in 2023 to $95.4 million by 2031,...

Find out if GLP-1 drugs is covered by Aetna, typical copay ranges, prior-auth rules, and affordable alternatives

31% of GLP-1 users drank less alcohol in the past year

A major new clinical trial is putting a spotlight on one of the biggest conversations in medicine right now: what happens when GLP-1based therapy is brought into psoriatic arthritis care

Eli Lilly and Novo Nordisk are closing in on deals with the Trump administration that would exchange deep discounts on their weight loss drugs for coverage under Medicare, per Endpoints News